139 related articles for article (PubMed ID: 33803570)
41. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
Shaikh MH; Khan AI; Sadat A; Chowdhury AH; Jinnah SA; Gopalan V; Lam AK; Clarke DTW; McMillan NAJ; Johnson NW
BMC Cancer; 2017 Nov; 17(1):792. PubMed ID: 29178862
[TBL] [Abstract][Full Text] [Related]
43. Folic acid supplementation increases survival and modulates high risk HPV-induced phenotypes in oral squamous cell carcinoma cells and correlates with p53 mRNA transcriptional down-regulation.
Moody M; Le O; Rickert M; Manuele J; Chang S; Robinson G; Hajibandeh J; Silvaroli J; Keiserman MA; Bergman CJ; Kingsley K
Cancer Cell Int; 2012 Mar; 12():10. PubMed ID: 22443202
[TBL] [Abstract][Full Text] [Related]
44. [Anogenital HPV Infection as the Potential Risk Factor for Oropharyngeal Carcinoma].
Sehnal B; Podlešák T; Kmoníčková E; Nipčová M; Driák D; Sláma J; Zikán M
Klin Onkol; 2018; 31(2):103-109. PubMed ID: 29708352
[TBL] [Abstract][Full Text] [Related]
45. Identification of human papillomavirus (HPV) subtype in oral cancer patients through microarray technology.
Kim SM; Kwon IJ; Myoung H; Lee JH; Lee SK
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):535-543. PubMed ID: 29224043
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus (HPV) in head and neck cancer.
Syrjänen S
J Clin Virol; 2005 Mar; 32 Suppl 1():S59-66. PubMed ID: 15753013
[TBL] [Abstract][Full Text] [Related]
47. Human papillomavirus and head and neck cancer: epidemiology and molecular biology.
McKaig RG; Baric RS; Olshan AF
Head Neck; 1998 May; 20(3):250-65. PubMed ID: 9570632
[TBL] [Abstract][Full Text] [Related]
48. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
49. Case-control study of human papillomavirus and oropharyngeal cancer.
D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML
N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927
[TBL] [Abstract][Full Text] [Related]
50. The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry.
Cleveland JL; Junger ML; Saraiya M; Markowitz LE; Dunne EF; Epstein JB
J Am Dent Assoc; 2011 Aug; 142(8):915-24. PubMed ID: 21804058
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Cancer; 2019 Jan; 125(2):249-260. PubMed ID: 30444527
[TBL] [Abstract][Full Text] [Related]
52. Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Bzhalava Z; Arroyo Mühr LS; Dillner J
Vaccine; 2020 May; 38(25):4066-4070. PubMed ID: 32362526
[TBL] [Abstract][Full Text] [Related]
53. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
[TBL] [Abstract][Full Text] [Related]
54. Role of human papillomavirus in non-oropharyngeal head and neck cancers.
Combes JD; Franceschi S
Oral Oncol; 2014 May; 50(5):370-9. PubMed ID: 24331868
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of human papillomavirus DNA and p16
Olesen TB; Sand FL; Rasmussen CL; Albieri V; Toft BG; Norrild B; Munk C; Kjær SK
Lancet Oncol; 2019 Jan; 20(1):145-158. PubMed ID: 30573285
[TBL] [Abstract][Full Text] [Related]
56. Role of Human Papillomavirus in Penile Carcinomas Worldwide.
Alemany L; Cubilla A; Halec G; Kasamatsu E; Quirós B; Masferrer E; Tous S; Lloveras B; Hernández-Suarez G; Lonsdale R; Tinoco L; Alejo M; Alvarado-Cabrero I; Laco J; Guimerà N; Poblet E; Lombardi LE; Bergeron C; Clavero O; Shin HR; Ferrera A; Felix A; Germar J; Mandys V; Clavel C; Tzardi M; Pons LE; Wain V; Cruz E; Molina C; Mota JD; Jach R; Velasco J; Carrilho C; López-Revilla R; Goodman MT; Quint WG; Castellsagué X; Bravo I; Pawlita M; Muñoz N; Bosch FX; de Sanjosé S;
Eur Urol; 2016 May; 69(5):953-61. PubMed ID: 26762611
[TBL] [Abstract][Full Text] [Related]
57. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
[TBL] [Abstract][Full Text] [Related]
58. Roles of Human Papillomaviruses and p16 in Oral Cancer.
Sritippho T; Chotjumlong P; Iamaroon A
Asian Pac J Cancer Prev; 2015; 16(15):6193-200. PubMed ID: 26434816
[TBL] [Abstract][Full Text] [Related]
59. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States.
Chaturvedi AK; Graubard BI; Broutian T; Pickard RKL; Tong ZY; Xiao W; Kahle L; Gillison ML
J Clin Oncol; 2018 Jan; 36(3):262-267. PubMed ID: 29182497
[TBL] [Abstract][Full Text] [Related]
60. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
